Harald Nusser is the head of global patient solutions at Gilead Sciences, working on sustainable business models to ensure that medicines are affordable and accessible around the world. He is also a global ambassador of the G20 Health & Development Partnership. Prior to joining Gilead, Harald was head of Novartis Social Business, and he supported The Defeat-NCD Partnership as a board member in 2018. Harald also spent 10 years at Bayer Pharmaceuticals and six years at Schering Pharmaceuticals. He holds a Ph.D. in Mathematics from Freie Universität Berlin and an Executive MBA from the University of Bradford.
